MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST002127/mwtabprimaryOK200MetabolomicsEIMass SpectrometryMus Musculushttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST002127Source_Name[gating]:Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Treatment:NR 1 week, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h | Batch:1e | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).Source_Name[gating]:Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Treatment:Ctrl, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | Batch:1e | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).Source_Name[gating]:Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Treatment:NR 1 week, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | Batch:1e | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).Source_Name[gating]:Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Treatment:Ctrl, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h | Batch:1e | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).Source_Name[gating]:Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Treatment:NR 1 week, [13C, 15N] AAs were incorporated for 1 h | Batch:1e | Note:[13C, 15N]AAs were used for AA uptake (FigS6.J)Source_Name[gating]:Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Treatment:NR 1 week, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | Batch:1e | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).Source_Name[gating]:Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Treatment:Ctrl, [13C, 15N] AAs were incorporated for 1 h | Batch:1e | Note:[13C, 15N]AAs were used for AA uptake (FigS6.J)Source_Name[gating]:Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Treatment:Ctrl, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | Batch:1e | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).Bone MarrowSun Yat-sen UniversityGC POSITIVE ION MODE.MetabolomicsWorkbench[13C, 15N]Glycine, 2TBDMS[13C, 15N]Lysine, 3TBDMS[13C, 15N]Phenylalanine, 2TBDMS[13C, 15N]Tyrosine, 3TBDMS[13C, 15N]Leucine, 2TBDMS[13C]Fumatate[13C, 15N]Serine, 3TBDMS[13C]Malate[13C, 15N]Alanine, 2TBDMS[13C, 15N]Aspartic acid, 3TBDMS[13C, 15N]Glutamic acid, 3TBDMS[13C]Succinate[13C]Alpha_Ketoglutarate[13C, 15N]Isoleucine, 2TBDMS[13C, 15N]Methionine, 2TBDMS[13C, 15N]Histidine, 3TBDMS[13C, 15N]Threonine, 3TBDMS[13C]Citrate[13C, 15N]Proline, 2TBDMS[13C, 15N]Valine, 2TBDMSAmino Acid, Acid, amino acids, Amino acids, Aminokarbonsaeure, Aminosaeure, Aminocarbonsaeure, Amino acid, Cell., Acids, alpha-amino acids, alpha-amino acid, Amino, alpha-amino carboxylic acidsiones., Ionen, ion, Ion, ionsfalseAmino acids and TCA substrates in hematopoietic cells (Part4)ST00212710090